Rituximab-Lenalidomide(R2) Maintenance Is Superior to Rituximab Maintenance After First Line Immunochemotherapy in Mantle Cell Lymphoma: Results of the Mcl R2 Elderly Clinical Trial

AuthID
 P-00X-4CM
24
Author(s)
Ribrag, V
·
Safar, V
·
Kluin Nelemans, H
·
Casasnovas, O
·
Thieblemont, C
·
Daguindau, N
·
Damaj, GL
·
[+4]·
da Silva, MG
·
Marin Niebla, A
·
Taszner, M
·
Walewski, J
·
Boersma, R
·
Delfau Larue, MH
·
Le Gouill, S
·
Dreyling, MH
View all authors
Document Type
Abstract
Year published
2021
Published
in BLOOD, ISSN: 0006-4971
Volume: 138
Indexing
Wos®
Google Scholar®
Publication Identifiers
Wos: WOS:000736398801155
Source Identifiers
ISSN: 0006-4971
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.
All authors
Name Order Name   Name Order Name   Name Order Name
1 Ribrag, V;   2 Safar, V;   3 Kluin Nelemans, H;
4 Oberic, L;   5 Feugier, P;   6 Casasnovas, O;
7 Thieblemont, C;   8 Daguindau, N;   9 Damaj, GL;
10 Klapper, W;   11 Hoster, E;   12 von Weikersthal, LF;
13 Haenel, M;   14 Andre, M;   15 da Silva, MG;
16 Carcinero, F;   17 Marin Niebla, A;   18 Taszner, M;
19 Walewski, J;   20 Boersma, R;   21 Houtenbos, I;
22 Delfau Larue, MH;   23 Le Gouill, S;   24 Dreyling, MH;

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service